(19)
(11) EP 4 007 609 A1

(12)

(43) Date of publication:
08.06.2022 Bulletin 2022/23

(21) Application number: 20758033.3

(22) Date of filing: 31.07.2020
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
C12N 15/86(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 48/0083; A61K 48/0075; C12N 15/86; C12N 2750/14143; C12N 2800/40; C12N 2800/30; C12N 2830/002
(86) International application number:
PCT/US2020/044598
(87) International publication number:
WO 2021/022208 (04.02.2021 Gazette 2021/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.08.2019 US 201962881540 P

(71) Applicant: Cornell University
Ithaca, NY 14850 (US)

(72) Inventor:
  • KAPLITT, Michael G.
    New York, New York 10021 (US)

(74) Representative: Secerna LLP 
The Old Fire Station 18 Clifford Street
York YO1 9RD
York YO1 9RD (GB)

   


(54) TARGETED GENE THERAPY TO TREAT NEUROLOGICAL DISEASES